179 related articles for article (PubMed ID: 24081803)
1. Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.
Ruys AT; Groot Koerkamp B; Wiggers JK; Klümpen HJ; ten Kate FJ; van Gulik TM
Ann Surg Oncol; 2014 Feb; 21(2):487-500. PubMed ID: 24081803
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis.
Li B; Tang H; Zhang A; Dong J
PLoS One; 2016; 11(6):e0157878. PubMed ID: 27305093
[TBL] [Abstract][Full Text] [Related]
3. Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Wiggers JK; Ruys AT; Groot Koerkamp B; Beuers U; ten Kate FJ; van Gulik TM
J Gastroenterol Hepatol; 2014 Aug; 29(8):1582-94. PubMed ID: 24787096
[TBL] [Abstract][Full Text] [Related]
4. Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.
Bergeat D; Fautrel A; Turlin B; Merdrignac A; Rayar M; Boudjema K; Coulouarn C; Sulpice L
J Surg Res; 2016 Jun; 203(2):441-50. PubMed ID: 27363654
[TBL] [Abstract][Full Text] [Related]
5. Prognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers.
Jones RP; Bird NT; Smith RA; Palmer DH; Fenwick SW; Poston GJ; Malik HZ
Biomark Med; 2015; 9(8):763-75. PubMed ID: 26223884
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis.
Xian F; Ren D; Bie J; Xu G
Front Immunol; 2023; 14():1119168. PubMed ID: 37138876
[TBL] [Abstract][Full Text] [Related]
7. Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma.
Sulpice L; Rayar M; Turlin B; Boucher E; Bellaud P; Desille M; Meunier B; Clément B; Boudjema K; Coulouarn C
J Surg Res; 2014 Nov; 192(1):117-23. PubMed ID: 24909871
[TBL] [Abstract][Full Text] [Related]
8. Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Li MX; Bi XY; Li ZY; Huang Z; Han Y; Zhao JJ; Zhao H; Cai JQ
J Surg Res; 2016 Jun; 203(1):163-73. PubMed ID: 27338547
[TBL] [Abstract][Full Text] [Related]
9. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.
Mantel HT; Wiggers JK; Verheij J; Doff JJ; Sieders E; van Gulik TM; Gouw AS; Porte RJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1107-15. PubMed ID: 26178761
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.
Liu YF; Zhao R; Guo S; Wang XQ; Lian PL; Chen YG; Xu KS
Ann Surg Oncol; 2011 Mar; 18(3):872-9. PubMed ID: 20848225
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Cholangiocarcinoma.
Saito N; Shirai Y; Horiuchi T; Sugano H; Shiba H; Sakamoto T; Uwagawa T; Yanaga K
Anticancer Res; 2018 Feb; 38(2):987-992. PubMed ID: 29374731
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of prognostic factors for overall survival and disease-free survival among resected patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Lv TR; Hu HJ; Ma WJ; Liu F; Jin YW; Li FY
Eur J Surg Oncol; 2024 Jan; 50(1):107279. PubMed ID: 38000116
[TBL] [Abstract][Full Text] [Related]
15. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
16. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
[TBL] [Abstract][Full Text] [Related]
17. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
[TBL] [Abstract][Full Text] [Related]
18. Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis.
Belkouz A; Labeur TA; Dierks J; Dijk F; van Oijen MGH; Verheij J; van Gulik TM; van de Vijver MJ; Wilmink H; Punt CJA; Klümpen HJ
Crit Rev Oncol Hematol; 2019 Sep; 141():82-94. PubMed ID: 31255992
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of fascin, E-cadherin and vimentin: Proteins associated with survival of cholangiocarcinoma patients.
Mao X; Chen D; Wu J; Li J; Zhou H; Wu Y; Duan X
Am J Med Sci; 2013 Oct; 346(4):261-8. PubMed ID: 23221510
[TBL] [Abstract][Full Text] [Related]
20. Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
Han Y; Zhang W; Liu Y
World J Surg; 2013 Oct; 37(10):2419-27. PubMed ID: 23793608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]